Assessor Blinded?

Baselineb and Change in PTSD Measure

Statistically Significant? (versus control)

Loss of Diagnosis (%)

Principal Limitations

Yes

69.9, 67.7,

 

 

41% dropout handled with LOCF; 28% differential dropout

 

72.0

Yes

27.6%

 

−16.8

Yes

31.8%

 

−20.5

 

17.4%

 

−6.5

 

 

Yes

68.2, 65.0,

 

 

 

 

65.8, DO 69.2

 

 

27.1% dropout rate; 21% differential dropout

 

 

Yes

76.2%

 

−44.5

Yes

44.4%

 

−24.9

 

 

 

−11.8

 

 

No

~72

 

NR

 

 

−15.02

 

 

39% dropout handled with LOCF and mean replacement; 39% differential dropout; no assessor blinding or independence

 

−19.17

Yes

 

 

−5.88

Yes

 

Yes

25.2, 2.0, 19.5

 

(at 1-year follow-up)

No major limitations

 

−6.1

Yesf

 

 

−2.2

No

71%

 

+1.7

 

21%

 

 

 

20%

NR

NR

No

NR

Dropout or completer numbers not reported; no assessor blinding or independence not reported; outcomes reported aggregated for treatment groups

 

−8.1 (both Tx groups)

 

 

 

−3.8

 

 

Yes

~30

 

 

27% dropout handled with LOCF; 27% differential dropout

 

−17.8

Yes

60%

 

−16.5

Yes

42%

 

−16.4

Yes

40%

 

−6.0

0%



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement